Brabrand, Denmark

Niels Krog

This inventor holds 1 USPTO granted patent. Top assignee: Gs Development Ab. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niels Krog. Retrieved from https://idiyas.com/inventor/niels-krog

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niels Krog: Innovator in Controlled Release Compositions

Introduction

Niels Krog is a notable inventor based in Brabrand, Denmark. He has made significant contributions to the field of controlled release compositions, particularly in the medical sector. His innovative work focuses on the development of compositions that enhance the delivery of biologically active materials.

Latest Patents

Niels Krog holds 1 patent for a controlled release composition. This composition is designed for a biologically active material and is characterized by its liquid or liquid crystalline form. It includes at least one medium or long-chain fatty acid ester of diglycerol as a carrier for the biologically active material. This innovative composition is particularly useful as a medical formulation.

Career Highlights

Niels Krog is associated with Gs Development AB, where he continues to advance his research and development efforts. His work has the potential to significantly impact the medical field by improving the efficacy of drug delivery systems.

Collaborations

Niels collaborates with talented individuals such as Kåre Larsson and Helena Ljusberg-Wahren. Their combined expertise contributes to the innovative projects at Gs Development AB.

Conclusion

Niels Krog's contributions to controlled release compositions exemplify the importance of innovation in the medical field. His work not only enhances the delivery of biologically active materials but also paves the way for future advancements in medical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…